Dr. Anton Jetten received his Ph.D.in Microbiology from the University of Nijmegen, The Netherlands.Following postdoctoral fellowships at the Massachusetts Institute of Technology
and the Roche Institute of Molecular Biology, he joined the NCI in 1980 and the NIEHS in 1982 as principal investigator. He is Deputy Chief of the Immunity, Inflammation, and Disease Laboratory and Head of the Cell Biology Group. His research has been focusing on the study of the mechanisms of action and the physiological functions of members of the GLI-similar (GLIS) transcription factor and retinoic acid-related orphan receptor (ROR) subfamilies, and their roles in disease, including metabolic syndrome, diabetes, cystic kidney and inflammatory diseases, and cancer. He has published over 320 papers in scientific journals.
Dr. Anton Jetten received his Ph.D.in Microbiology from the University of Nijmegen, The Netherlands.Following postdoctoral fellowships at the Massachusetts Institute of Technology
and the Roche Institute of Molecular Biology, he joined the NCI in 1980 and the NIEHS in 1982 as principal investigator. He is Deputy Chief of the Immunity, Inflammation, and Disease Laboratory and Head of the Cell Biology Group. His research has been focusing on the study of the mechanisms of action and the physiological functions of members of the GLI-similar (GLIS) transcription factor and retinoic acid-related orphan receptor (ROR) subfamilies, and their roles in disease, including metabolic syndrome, diabetes, cystic kidney and inflammatory diseases, and cancer. He has published over 320 papers in scientific journals.